Trial Profile
Phase 1 study of CS-7017 in combination with FOLFIRI in subjects with Metastatic colorectal cancer(CRC)who failed First-line therapy
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 19 Feb 2018
Price :
$35
*
At a glance
- Drugs Efatutazone (Primary) ; Fluorouracil; Folinic acid; Irinotecan
- Indications Colorectal cancer
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Daiichi Sankyo Company
- 11 May 2015 New trial record